Results 141 to 150 of about 7,946 (150)

Preclinical pharmacology of the α4β2 nAChR partial agonist varenicline related to effects on reward, mood and cognition

Biochemical Pharmacology, 2009
Mihály Hajos, William E Hoffmann, Rouba Kozak   +2 more
exaly  

Varenicline

Reactions Weekly, 2022
openaire   +1 more source

Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid

Neuropharmacology, 2007
exaly  

Discovery and development of varenicline for smoking cessation

Expert Opinion on Drug Discovery, 2018
Zheng-Xiong Xi, Chloe Jordan
exaly  

Varenicline in the routine treatment of tobacco dependence: a pre–post comparison with nicotine replacement therapy and an evaluation in those with mental illness

Addiction, 2008
exaly  

Multiple‐Dose Pharmacokinetics of the Selective Nicotinic Receptor Partial Agonist, Varenicline, in Healthy Smokers

Journal of Clinical Pharmacology, 2006
Hélène Faessel
exaly  

Varenicline

Reactions Weekly, 2013
openaire   +1 more source

Varenicline in smokers with diabetes: A pooled analysis of 15 randomized, placebo‐controlled studies of varenicline

Journal of Diabetes Investigation, 2017
exaly  

Varenicline in the Treatment of Alcohol Use Disorders

Annals of Pharmacotherapy, 2014
exaly  

Treatment of imbalance with varenicline (Chantix®): report of a patient with fragile X tremor/ataxia syndrome

Acta Neurologica Scandinavica, 2009
exaly